1. Introduction {#sec1}
===============

Neglect as well as physical and sexual abuse of minors are highly prevalent in the United States, with approximately 676,000 child victims and 3.5 million child protective services investigations in 2016 ([@bib165]). Stressful experiences during childhood and adolescence, a time when brain regions important for executive function and reward processing are still developing, can have long lasting influences into adulthood. The goal of the current review is to provide a working neurobiological model describing how early-life adversity may influence substance use during adulthood, which will inform future directions in the field. To do so, we will introduce the problem of early-life adversity and the influence it has on substance use later in life, discuss corticotropin-releasing factor (CRF) and serotonin as major players in early-life stress outcomes in adulthood, and give an overview of the development of both CRF and serotonin systems and associated sex differences that may increase vulnerability to the effects of early-life adversity. Finally, we will describe how these systems interact and are influenced by early-life adversity to increase substance use susceptibility later in life.

2. The problem of early-life adversity and substance use {#sec2}
========================================================

Childhood, peri-adolescence (early through late adolescence including puberty), and early adulthood mark a particularly vulnerable time to the effects of stress. Exposure to stress early in life may be particularly deleterious on behavioral outcomes in adulthood given the correspondence these time periods have to brain development (for review see [@bib84]; [@bib85]). In humans, early-life adversity arising from physical, emotional, and sexual abuse correlates with an increased risk of substance use and other mental health disorders including anxiety disorders, major depressive disorder, and schizophrenia ([@bib46]; [@bib68]; [@bib39]; [@bib110]; [@bib148]). Children exposed to early-life adversity through abuse and/or neglect also have increased risk of drug use, relapse following drug abstinence, and overall increased prevalence of substance use disorders during adulthood ([@bib111]; [@bib170]; [@bib159]). Adolescents from a family with a history of substance use disorders have an increased likelihood of experiencing more frequent and severe stressors, and initiation of substance use is indirectly influenced by stress exposure; indicative of a cycle of stress and substance use ([@bib32]; [@bib31]). Adults that report childhood sexual abuse also report earlier initiation of and increased use of illicit drugs ([@bib66]; [@bib123]; [@bib119]). Furthermore, children exposed to two or more stressful life events have an increased risk for developing alcohol dependence compared to children that did not experience any stressful life events ([@bib131]), with stress likely being a greater mediating factor in women compared to in men ([@bib151]; [@bib187]; [@bib45]). Similarly, in women, emotional abuse has a stronger association with age of first alcohol use and severity of substance abuse compared to men ([@bib73]), and childhood emotional abuse is associated with cocaine relapse in women but not in men ([@bib74]). Combined, these findings imply that trauma or stress early in development may play a more prominent role in promoting adult drug-taking behaviors in women. These data suggest that women have a higher likelihood for a stress-induced trajectory to drug taking, resulting in a more rapid transition from drug taking to dependence and greater propensity for relapse compared to men ([@bib71]; [@bib16]). Overall, it appears that exposure to adverse experiences early in life increases risk of substance use during adulthood, but it is important to note that not all children exposed to early-life adversity go on to develop a substance use disorder, arguing for the importance and contribution of both genetics, epigenetics, and the influence of other environmental factors that may contribute to these individual differences.

3. Effects of early life adversity on reward processes and drug responses in preclinical models {#sec3}
===============================================================================================

Three main types of paradigms have been used in rodents to model early-life adversity and directly test the impact of early-life stress on drug-related behaviors. These include social isolation/social disruption, social defeat stress, and maternal separation, which differ in the developmental period of stress exposure ([Fig. 1](#fig1){ref-type="fig"}, see figure legend for age ranges corresponding to weaning, peri-adolescence, adolescence and puberty). Social isolation/disruption from weaning to either mid-adolescence or up to adulthood ([Fig. 1](#fig1){ref-type="fig"}) interrupts the development of play behavior and results in aggression, anxiety, and hyperactivity during adulthood ([@bib63]; [@bib172]; [@bib67]; [@bib102]; [@bib182]). Social isolation/disruption during periods of development corresponding to pre-pubescence and adolescence results in a sensitized response to amphetamine ([@bib109]; [@bib107]), enhanced acquisition of cocaine self-administration at low doses, and decreased acquisition at higher doses in adulthood ([@bib146]; [@bib21]; [@bib130]; [@bib70]; [@bib90], [@bib91]; [@bib92]; [@bib191]; [@bib57]; [@bib7]). Further, social isolation/disruption during a more discreet period of development from postnatal day (PND) 21--42 (weaning to mid-adolescence) followed by weeks of re-socialization results in increased motivation for cocaine while not altering extinction responding, or cue- cocaine- or yohimbine-induced reinstatement of cocaine seeking during adulthood ([@bib7]). Alterations in drug-taking behavior are not specific to stimulants, given that social isolation/disruption from weaning to early adulthood also increases ethanol consumption and self-administration during adulthood in both rats and mice ([@bib108]; [@bib96]). Increased sensitivity to opiates is often reported following post-weaning social isolation, but findings are not always consistent among the different paradigms ([@bib1a]). For example, social isolation increases morphine and sufentanil self-administration but decreases morphine or heroin preferences in conditioned place preference tasks ([@bib3]; [@bib185]; [@bib144], [@bib145]; [@bib81]). Together, these studies indicate that social isolation/disruption following weaning typically results in increased self-administration of a variety of drug classes and often enhances other indices of substance-associated behaviors during adulthood.Fig. 1Timeline of neural development of the corticotropin-releasing factor (CRF) and dorsal raphe nucleus (dRN) serotonin systems in relation to the time periods in which different stress paradigms are employed. Note that peri-adolescence for the rat is considered to begin at weaning (PND 21), encompassing adolescence from PND 32 to PND 56--60 (although adolescence may begin later in males) ([@bib149]). Rats are thought to attain puberty by PND 50 ([@bib149]). The time period in which each early-life stress paradigm is indicated represents the age ranges used by a majority of studies described here, although a number of social isolation/disruption or social defeat studies use more specific age ranges to restrict stress to discrete developmental periods, as detailed in the text. CRF expression in the central nucleus of the amygdala (CeA; gray bar) is thought to increase over development, whereas CRF receptor expression (solid lines) in most brain regions peaks very early in postnatal development. As indicated by the bifurcating black solid line, CRF receptor expression shows a second developmental change over puberty, with either a decrease or increase in expression dependent on brain region studied, sex of individual and receptor (CRF~1~ or CRF~2~). The expression of tryptophan hydroxylase 2 (TPH2) in the dRN (dashed lines), as a measure of serotonin levels/neurons, increases over development in males, but peaks around PND42 in females and then declines to adulthood. See text for citations.Fig. 1

Social defeat involves an imbalance of power between a dominant and subordinate animal. Social defeat stress can be used as a model of peer victimization and bullying frequently experienced during childhood and adolescence ([Fig. 1](#fig1){ref-type="fig"}) ([@bib18]; [@bib181]; [@bib26]). This type of stress during the adolescent period effectively results in heightened novelty seeking and risk taking in adulthood ([@bib181]) along with executive function deficits ([@bib121]; [@bib182]). Social defeat in pre-adolescence (e.g., PND 14--38) increases conditioned place preferences for cocaine and MDMA, and enhances alcohol consumption and motivation to administer alcohol in adulthood ([@bib95]; [@bib54]; [@bib138]). Similarly, social defeat restricted to mid-adolescence (PND 35--44) results in augmented locomotion following a low dose of amphetamine and increased amphetamine conditioned place preference during adulthood ([@bib28], [@bib25]). Adolescent social defeat also increased the percentage of rats that voluntarily acquired the task of cocaine self-administration acquisition, the motivation to lever press for cocaine as measured using a progressive ratio schedule, and the amount of cocaine consumed when given unlimited access during a 24 h binge later in life ([@bib27]; [@bib24]). Furthermore, a metric used to determine how stressful the social defeat was during adolescence in individual rats was positively correlated with the amount of cocaine consumed under progressive ratio and unlimited access schedules approximately 40 days later in adulthood ([@bib27]; [@bib24]). Thus, similar to the social isolation model, social defeat stress applied either prior to or during adolescence effectively enhances drug and alcohol responding in adulthood, suggestive of long-term effects of stress on reward-associated neural systems.

Maternal separation is used to describe a variety of neonatal paradigms during which the pups are separated from the mother for various lengths of time (for review of methodologies see [@bib89]; [@bib122]; [@bib162]). Studies using this paradigm often have inconsistent timing and lengths of separation (i.e., methodologies), making comparisons difficult. Despite these shortfalls, there are remarkable consistencies regarding the influence that prolonged (three or more hrs) daily maternal separation has on later drug reactivity and responding for drugs in adulthood. Maternal separation from PND 1--14 increases the rewarding effects of acute amphetamine exposure during adulthood, as measured by a decrease in intracranial self-stimulation current threshold ([@bib43]). Similar to findings following social isolation/social disruption, maternal separation results in greater methamphetamine self-administered and earlier acquisition while not altering extinction or cue-induced reinstatement ([@bib115]; [@bib94], [@bib93]). Exposure to maternal separation also has effects on alcohol and opiate intake and preferences during adulthood. To illustrate, male rats exposed to maternal separation exhibit increased self-administered alcohol binge drinking, corresponding to increased impulsivity and increased ethanol preference ([@bib72]; [@bib132]; [@bib79]; [@bib58]), heightened morphine conditioned place preference and increased morphine self-administration ([@bib112]; [@bib2a], [@bib173]; [@bib3a]).

Overall, these findings indicate that the long-lasting effects of early-life adversity may be conserved across various drug classes. Collectively these studies also demonstrate that social isolation/social disruption, social defeat, and maternal separation have similar outcomes for drug-related behaviors in adulthood despite their different methodologies and the variety of developmental time periods in which these stressors are experienced ([Fig. 1](#fig1){ref-type="fig"}). Interestingly, similar outcomes are noted with prenatal stressors ([@bib82]; [@bib135]). This suggests that there may not be a critical period in development by which stress has negative consequences for later substance use, and instead, any period of development early in life is a sensitive time for the effects of stress. However, due to the different stages of brain development affected by each specific early-life adversity model ([Fig. 1](#fig1){ref-type="fig"}), it is likely that the underlying neural substrates promoting enhanced drug taking or preferences differ among the developmental stressors (discussed further in Section [6](#sec6){ref-type="sec"}).

Despite sex differences in the prevalence of mental health disorders including anxiety disorders, major depressive disorder, and substance use disorders ([@bib153]; [@bib160]; [@bib71]; [@bib16]; [@bib168]), little work in rodent studies has been done to characterize the influence of stress during development in both males and females on outcomes in adulthood. Furthermore, the differential trajectory of brain development ([@bib15]; [@bib9]) urges for further investigation in both males and females. Studies that have probed for potential sex differences in the effects of early-life adversity on later drug or alcohol measures in rodents are surprising. Contrary to the findings discussed above ([@bib151]; [@bib187]; [@bib45]), where early-life adversity has a greater impact on later alcohol use in women, rodent studies either fail to find a sex difference or show that female rodents are not affected by the early-life stressor when alcohol preference or intake is measured in adulthood (e.g. [@bib139]; [@bib62]; [@bib96]). It is possible that the effects of early-life adversity in female rodents are more apparent for responses to stimulants. For example, female rats briefly handled during week two of life show increased self-administration of cocaine during adulthood, whereas males do not ([@bib47]). Likewise, social instability stress from PND 33--48 results in increased nicotine-induced locomotion in adult female but not male rats ([@bib109]). However, there are just as many instances where stimulant responses in males and females during adulthood are similar following early-life adversity. For example, maternal separation for an hour a day from PND 2--12 increases responding for cocaine during extinction and cue-induced reinstatement similarly in both male and female rats ([@bib105]). Also, social instability of rats from PND 30--45 increases amphetamine-induced locomotion equally among both sexes ([@bib107]). Further work is needed to determine whether animal models sufficiently model human sex differences in the impact of early-life adversity on later substance use, and to determine whether any sex differences in stress and drug responsivity are due to the activational rather than organizational effects of gonadal hormones (for review see [@bib9]).

The exact neurobiological mechanisms through which early-life adversity leads to increased substance use in adulthood remain to be elucidated. Numerous preclinical studies have shown that stress experienced in early-life results in long term functional alterations in the mesocorticolimbic system and corresponding changes in reward processing, particularly in enhancing responses to a range of abused substances (see [@bib115]; [@bib113]; [@bib45]; [@bib11]; [@bib42]; [@bib182] for reviews). Not surprisingly, many of the observed neurobiological effects involve direct changes to dopaminergic signaling in the nucleus accumbens (NAc), along with modifications to activity of other stress-responsive factors that impinge upon accumbal function either directly or indirectly, including CRF, GABAergic, glutamatergic, noradrenergic, neurotrophic, opioid, and glucocorticoid systems (see [@bib49]; [@bib152]; [@bib11]; [@bib106]; [@bib78]; [@bib182]). Here, we will focus on a neural system characterized by CRF-serotonin interactions that is upstream of the dopaminergic mesocorticolimbic pathways, and we will examine the emerging body of converging evidence suggesting that early life stress has long-term effects on the functioning of the CRF-serotonin system.

4. Corticotropin-releasing factor (CRF) and serotonin interactions mediating stress and reward reponses {#sec4}
=======================================================================================================

Topographically organized, functional subsets of serotonergic neurons of the dorsal raphe nucleus (dRN) are often associated with mediating the negative consequences of early life adversity ([@bib98]; [@bib102]; [@bib26]) and also with drug-associated behaviors ([@bib175]; [@bib166]). Similarly, the actions of the stress-related neuropeptide CRF in the brain have been implicated in early life adversity and addiction ([@bib152]; [@bib102]; [@bib86]). The dRN is a major site for CRF interactions with a distributed serotonergic system, and the neurons of the dRN receive CRF projections likely from specific subregions of the central nucleus of the amygdala (CeA) and bed nucleus of the stria terminalis (BNST) ([@bib60]; [@bib52]). Both local GABAergic interneurons and serotonergic projection neurons of the dRN subregions are targeted by CRF terminals and both neuronal types possess CRF~1~ and CRF~2~ receptors ([@bib40]; [@bib179]; [@bib103], [Fig. 2](#fig2){ref-type="fig"}). Both serotonin and CRF are implicated in behavioral and emotional states that are risk factors for substance use and dependence, such as anxiety, dysphoria, and impulsivity ([@bib97]; [@bib102]; [@bib166]; [@bib36]; [@bib116]; [@bib125]; [@bib137]). Therefore it is not surprising that CRF-dRN interactions and resultant serotonergic output to the extended limbic system have gained attention as a potential important mediator linking stress to addiction (e.g. [@bib175]; [@bib147]; [@bib166]).Fig. 2Simplified schematic diagram illustrating how corticotropin-releasing factor (CRF) receptor activity in the dorsal raphe nucleus (dRN) may increase dopamine release in the nucleus accumbens (NAc). Stressors and drugs of abuse increase release of CRF in the dRN (a presumptive functional CRF projection has been indicated from the central nucleus of the amygdala \[CeA\] and/or the bed nucleus of the stria terminalis \[BNST\]). CRF activation of CRF~2~ receptors in the dRN appear to increase serotoninergic neural activity and serotonin output likely via CRF~2~ Gs-coupled receptor excitation of serotonergic neurons. Resultant serotonin released in the ventral tegmental area (VTA) can increase dopamine cell firing and NAc dopamine release via activation of serotonin type 2A (5-HT~2A~) or type 3 (5-HT~3~) receptors on dopamine neurons, or by disinhibition via 5-HT~1B~ inhibition of inhibitory GABAergic neurons. Furthermore, serotonin released in the NAc facilitates dopamine release in the NAc via presynaptic 5-HT~2A~ and 5-HT~3~ receptors located on dopamine terminals. See text for citations. Note that 5-HT~2C~ receptors located on GABAergic neurons do not appear to play a major role in increasing mesoaccumbal dopamine release as activation of these receptors result in hyperpolarization of dopaminergic neurons presumably via activation of GABAergic neurons, and thus reduce NAc dopamine release ([@bib118]).Fig. 2

Generally, findings from electrophysiological studies within the dRN and measures of serotonin release in limbic structures following global dRN manipulation align to conclude that CRF~1~ receptor activity decreases, whereas CRF~2~ receptor activity increases, dRN serotonergic neuronal activity and serotonin release ([@bib83]; [@bib4]; [@bib128]; [@bib51]; [@bib99], [@bib100]; [@bib180]). Although both receptor types are localized to serotonergic and GABAergic neurons in the dRN, the opposing effects of CRF~1~ vs CRF~2~ receptors on serotonergic output from this region may reflect predominant excitation of GABAergic neurons in the dRN by CRF~1~ receptors and activation of serotonergic neurons by local CRF~2~ receptors ([Fig. 2](#fig2){ref-type="fig"}). Of relevance, CRF~2~ receptors appear to be equally localized to serotonergic and GABAergic neurons in the caudal dRN but are almost exclusively localized to serotonergic neurons in the rostral dRN ([@bib40]), which may account for a predominant increase in serotonin output from the dRN when CRF~2~ receptors are globally activated by pharmacological manipulation of the dRN. While CRF~1~ receptors in other brain regions are more often associated with stress responses and fear or anxiety-like behaviors in preclinical models ([@bib69]; [@bib154]; [@bib161]; [@bib117]; [@bib56]), there appears to be a more important role for CRF~2~ receptors specifically in the dRN in mediating adaptive and maladaptive stress responses ([@bib102]; [@bib180]; [@bib189]). For example, activation of CRF~2~, but not CRF~1~, receptors throughout the dRN results in increased serotonin release in various amygdala subregions, prefrontal cortex and NAc ([@bib4]; [@bib51]; [@bib99]; [@bib147]), and pharmacological blockade of CRF~2~ receptors in the dRN reduces fear or anxiety-like behaviors in a variety of animal models ([@bib158]; [@bib65]; [@bib38]; [@bib175]; [@bib101]; [@bib19]). Interestingly, CRF~1~ and CRF~2~ receptors differentially respond to stress ([@bib180]; [@bib189]) which may account for the prominent role of dRN CRF~2~ receptors in stress-related outcomes. Within the dRN, CRF~2~ receptors are trafficked to the neuronal membrane while CRF~1~ receptors are internalized in response to an acute swim stress or chronic social stress ([@bib180]; [@bib189]). These molecular changes manifest in stress-induced alterations in dRN serotonergic neuronal firing patterns that shift from CRF~1~-mediated inhibition to CRF~2~-mediated excitation, accompanied by a change in cognitive performance that is dependent upon increased cortical serotonin transmission ([@bib180]; [@bib189]; [@bib157]). Overall, the CRF~2~ receptor in the dRN plays an important role in facilitating serotonergic transmission in the limbic system, which appears to become more pronounced in response to both acute and chronic stress.

The activity of CRF~2~ receptors in the dRN represents a potential neurobiological mechanism underlying the link between stress and drug seeking. Increased serotonin release in the NAc is elicited by CRF~2~ receptor activation in the dRN and enhanced by stress ([@bib99], [@bib100]). Serotonin in the NAc can, in turn, increase NAc dopamine release ([Fig. 2](#fig2){ref-type="fig"}; [@bib126]; [@bib41]) and dopaminergic activity in the NAc is strongly implicated in reward salience and drug seeking ([@bib10]; [@bib163]; [@bib44]; [@bib59]; [@bib129]; [@bib48]). Specifically, activation of 5-HT~2A~ and 5-HT~3~ receptors within the NAc increases accumbal dopamine release likely via direct actions on dopamine terminals ([Fig. 2](#fig2){ref-type="fig"}), and augments associated responses to drugs of abuse ([@bib126]; [@bib41]; [@bib127]; [@bib20]; [@bib192]; [@bib120]; [@bib2]). While serotonin in the dopamine cell body region of the ventral tegmental area (VTA) can enhance NAc dopamine release either directly via 5-HT~2A~ and 5-HT~3~ receptors on dopamine neurons or via 5-HT~1B~ receptor disinhibition via GABAergic neurons ([Fig. 2](#fig2){ref-type="fig"}; [@bib192]; [@bib2]), it is actions of serotonin in the NAc, but not the VTA, that are critical for serotonergic modulation of the rewarding effects of intracranial self-stimulation and psychostimulants ([@bib80]). Given that CRF~2~ receptor responses in the dRN are augmented after stress ([@bib100]; [@bib180]; [@bib189]), these converging lines of evidence suggest that drug seeking enhanced by stress may result in part from dRN CRF~2~ receptor-driven serotonergic facilitation of NAc dopamine release.

In other monoaminergic cell body regions, the stimulatory effects of CRF~2~ receptors appear to be related to the presence or activity of the CRF binding protein (CRF-BP). While traditionally thought of as a 'ligand-sink' ([@bib77]), the CRF-BP is necessary for CRF~2~ receptor-mediated potentiation of NMDA-induced activation of dopamine neurons in the VTA ([@bib164]) and plays an important role in stress-induced reinstatement of cocaine self-administration that is dependent on CRF~2~ receptor activation in the VTA ([@bib178]). Therefore, it has been suggested that the CRF-BP may play a permissive role in CRF\'s actions at the CRF~2~ receptor in the VTA ([@bib164]). Moreover, the CRF-BP promotes trafficking of CRF~2α~ receptors (neural CRF~2~ receptors) to the cellular membrane in cultured mesencephalic neurons ([@bib155]). Whether the CRF-BP plays similar roles in the dRN is an important future direction, as the CRF-BP may provide a novel pharmacological target to manipulate CRF~2~ receptor function and trafficking in the dRN following early-life adversity.

5. Ontogeny and sexual dimorphism of CRF-Serotonin systems {#sec5}
==========================================================

The CRF system, with its influence on monoaminergic function in the brain, is well positioned to be affected by stressors from early in life and throughout maturation ([Fig. 1](#fig1){ref-type="fig"}), with potential long-term consequences for later drug-related behaviors. This is because CRF expression peaks early in development (PND 8) within the paraventricular nucleus of the hypothalamus (PVN), and later in other brain regions such as the hippocampus (PND 18) ([@bib35]; [@bib88]). An exception to this is CRF expression in the CeA, which appears to increase over the course of development alongside increasing expression of the CRF-BP in this region ([@bib173]). Given that one target of CRF afferents from the CeA is likely the dRN ([@bib60]), this latter finding provides the intriguing possibility that CRF innervation of, or CRF activity in the dRN similarly increases over maturation and could be more susceptible to perturbation over a longer developmental period than other neural CRF systems.

The expression of CRF receptors in the brain initially was also thought to peak very early in development, with rat whole brain homogenates showing increases from birth to peak at PND 8, declining thereafter through the rest of development ([@bib75]). In a similar timeframe, CRF receptor mRNA expression peaks between PND 2--9 in the hippocampus, amygdala, and cortex ([@bib6]). However, when studies have included later developmental time points and examined both sexes, clear pre- and post-pubertal sex differences emerge for CRF receptor ontogeny that are often receptor and brain region specific. For example, CRF~1~ receptor expression is similar among male and female pre-pubertal rats in the amygdala, but decreases in males and increases in females after puberty (measured in adulthood at PND 98; [@bib183], [@bib184]). Of the variety of corticolimbic brain regions studied, each with their own sex- and age-dependent changes in CRF~1~ receptor expression, a general pattern of greater CRF~1~ receptor expression in post-pubertal females emerges ([@bib183], [@bib184]). In contrast, amygdala CRF~2~ receptor expression is higher in adult males because of an increase in CRF~2~ receptor expression over adolescence that is absent in females ([@bib183], [@bib184]). Greater CRF~2~ receptor expression in males also holds true for many other limbic brain regions ([@bib184]). Overall, there appears to be a sex difference in CRF~1/2~ receptor expression in the post-pubertal brain as a result of differential maturation patterns. Males have greater CRF~2~ receptor expression as adults whereas females exhibit greater expression of anxiogenic CRF~1~ receptors throughout adolescence. These latter findings suggest a possible mechanism for higher incidence of anxiety disorders in females ([@bib183]).

Only one study to date ([@bib104]) has explored the ontogeny and sexual dimorphism of CRF receptors within the dRN, and currently no information regarding sex-dependent expression or the developmental trajectory of the CRF-BP in the dRN is available. Overall, there is very little developmental change in either CRF~1~ or CRF~2~ mRNA in the dorsal and ventrolateral subregions of dRN from early adolescence (PND 25) to adulthood (PND 90) ([@bib104]). Earlier ages were not examined, leaving the possibility that CRF receptor expression in the dRN, like other brain regions (e.g., [@bib75]; [@bib6]), peaks very early in development. However, like other brain regions, clear sex differences in CRF receptor expression are apparent in subregions of the dRN that project to the cortex and NAc ([@bib104]). In contrast to other brain regions discussed earlier, CRF~2~ receptor mRNA expression in the dorsal ventrolateral dRN is higher in females compared to males ([@bib104]). Whether this results in a change of the net activity of the dRN to affect serotonergic output to the limbic system in a sex-specific manner is not known, but if this is the case, it may help explain the increased risk for females in the development of stress psychopathology, including stress-induced drug relapse ([@bib153]; [@bib160]; [@bib71]; [@bib16]).

The exact mechanisms underlying sexual dimorphism of CRF receptor expression are not understood, but sex steroids may play an important role given the greater divergence in expression in post-pubertal animals ([@bib183], [@bib184]; [@bib104]). For instance, non-aromatizable androgen administration to castrated male rats increases CRF~2~ mRNA in a variety of limbic structures ([@bib186]). This effect aligns with the natural pattern of higher CRF~2~ receptor expression in the same limbic regions of the male brain ([@bib183], [@bib184]), and suggests that such heightened CRF~2~ receptor expression in post-pubertal males is mediated by androgens or androgenic metabolites such as dihydrotestosterone and 3α-andronstanediol. However, it is unclear how such findings relate to the contrasting higher expression of CRF~2~ mRNA in the dorsal ventrolateral dRN of females ([@bib104]), especially as only male rats and mice express androgen receptors in the dRN ([@bib150]). Alternatively, the pattern seen in the dRN of females may reflect actions of estrogenic steroids, receptors for which are also located in the rodent dRN ([@bib150]). Support for an estrogen-mediated effect comes from studies showing that estradiol upregulates CRF~2~ receptor mRNA expression in the dRN of nonhuman primates ([@bib141]; [@bib17]), possibly via demethylation of the CRF~2~ receptor gene promoter that has been observed in myocardial cells ([@bib37]). Further research that examines the effects of sex steroids on both CRF receptor types in a variety of limbic and monoamine cell body brain regions will clarify a potential and differential role for these hormones in the sexually dimorphic pattern observed over later development.

In addition to sex differences in total cell expression of CRF receptors, differences between males and females in CRF receptor cell surface expression, receptor trafficking and G-protein coupling have been documented ([@bib12], [@bib14]; [@bib167]; [@bib13]). For example, female rats show greater coupling of cortical CRF~1~ receptor-Gs protein coupling in control conditions, whereas stress increases this coupling in male rats to female stress-naïve levels, and has no effect in females ([@bib12]). Furthermore, stress enhances the association between cortical CRF~1~ receptors and β-arrestin2 (necessary for receptor internalization) in males only ([@bib12]). The sex difference in β-arrestin2 association with CRF~1~ receptors is in line with observations of CRF-induced or stress-induced internalization of CRF receptors in the locus coeruleus (LC) of males and recruitment of CRF receptors to the cellular membrane in the LC of females ([@bib12], [@bib14]). Similarly, proestrus female rats exhibit higher membrane localization of CRF~1/2~ receptors in hippocampal dendrites compared to males ([@bib188]), suggestive of differential CRF receptor trafficking in the hippocampus among the sexes. Interestingly, there appears to be little role of ovarian steroids since ovariectomy does not alter the coupling or trafficking of CRF receptors in the cortex or LC of females ([@bib12]). Overall, it appears that increased sensitivity of neurons in the female brain to CRF ([@bib12], [@bib14]; [@bib13]) may result from increased coupling to Gs proteins, and that sex differences in stress responses and stress-related psychiatric illness could be explained by differential effects of stress on CRF receptor coupling and trafficking (Valentino et al., 2012, 2013; [@bib13]). While stress-induced receptor trafficking is certainly an important phenomenon in the dRN ([@bib180]; [@bib189]), it remains to be seen whether there are sex differences in CRF receptor coupling or trafficking in this serotonergic region.

Like CRF receptor expression, TPH2 mRNA expression is sexually dimorphic, with levels increasing throughout adolescence in males, but peaking at PND 42 in females before declining into adulthood ([@bib104]). Since TPH2 mRNA expression reflects TPH2 levels in neurons ([@bib8]), the latter finding strongly suggests differential serotonergic activity in the dorsal ventrolateral dRN in males and females over late adolescence that may help explain sexually dimorphic outcomes in response to stress exposure during this time ([@bib26]). In contrast to the lack of change in CRF receptor expression across adolescence in the dRN discussed earlier, tryptophan hydroxylase 2 (TPH2; an isozyme of the rate-limiting enzyme of serotonin synthesis) mRNA expression increases in the dorsal ventrolateral dRN, suggesting increased serotonergic activity over development ([@bib104]). This pattern mirrors the increase in serotonin and its metabolite 5--hydroxyindoleacetic acid (5-HIAA) that is observed in limbic and brainstem structures up until at least mid-adolescence (PND 45) ([@bib33]).

Overall, the earlier developmental processes characterizing the CRF system, combined with later sex-specific maturation of CRF receptors and serotonergic activity, places CRF interactions with the serotonergic dRN in a prime position to be affected by stressors from very early postnatal development to at least mid-adolescence ([Fig. 1](#fig1){ref-type="fig"}). Therefore, dysfunction of CRF-serotonin interactions at the level of the dRN may represent an important neural mechanism by which early-life adversity increases the risk for drug-associated problems later in life.

6. Early-life adversity alters CRF-Serotonin interactions and drug-related behaviors {#sec6}
====================================================================================

Early-life adversity exerts effects on CRF and serotonergic signaling in mesolimbic reward circuitry that can persist into adulthood ([@bib133]; [@bib113]; [@bib102]; [@bib29]), with deleterious consequences for reward processing and goal-directed behavior. For example, peri-adolescent social stress (social isolation/disruption or social defeat) has been shown to upregulate CRF~2~ receptors in the lateral dRN of adult male rats ([@bib100]; [@bib19], [Fig. 3](#fig3){ref-type="fig"}A and B). This effect is specific to CRF~2~ receptors, as expression and activity of CRF~1~ receptors in the adult dRN is not altered by either peri-adolescent stressor ([@bib100]; [@bib19], [Fig. 3](#fig3){ref-type="fig"}A and B). Moreover, the upregulation of CRF~2~ receptors in rats defeated in adolescence is only evident in the dRN, and is not seen in either the VTA or the locus coeruleus (LC, [Fig. 3](#fig3){ref-type="fig"}C). Increased CRF~2~ receptors in the lateral dRN following peri-adolescent stress results in prolonged CRF~2~-induced serotonin release in the NAc core in adulthood ([@bib100]). As described earlier, increased serotonin in the NAc facilitates dopamine release in this region via direct actions on serotonin receptors ([Fig. 2](#fig2){ref-type="fig"}), and augments responses to drugs of abuse ([@bib126]; [@bib127]; [@bib120]; [@bib2]). Drugs of abuse also activate extrahypothalamic CRF neurons and increase CRF levels in the brain ([@bib142]; [@bib136]; [@bib193]). Thus, drug- or stress-induced increases in CRF~2~ receptor activation in the dRN following peri-adolescent stress, and the influence of this on accumbal serotonin and dopamine, represents a neural substrate linking stress experience during adolescence with increased drug responsivity and drug seeking later in life. It should be noted that the studies to date have been performed exclusively in male rodents. As discussed earlier, females have greater CRF~2~ receptor mRNA expression and also higher TPH2 mRNA levels in the dorsal ventrolateral dRN ([@bib104]) that could play an important role in sexually-dimorphic responses to early-life adversity. However, neither the effects of social isolation nor defeat on CRF receptors in the dRN and resultant accumbal monoaminergic activity have been determined for females.Fig. 3Corticotropin-releasing factor (CRF) receptor expression in monoaminergic cell body regions was measured from adult male rats (PND 60) using methods described by [@bib100]. Rats were exposed to either adolescent social defeat or control handling conditions from PND 35--39, as detailed by [@bib181] -- a paradigm known to increase cocaine and amphetamine responses in adulthood ([@bib28], 2013, 2016; [@bib27]). A) Representative Western blot images of CRF~2~ receptor, CRF~1~ receptor, and actin (loading control) expression in the dorsal raphe nucleus (dRN). **B)** CRF~2~, but not CRF~1~ receptor expression was increased in the dRN of adult male rats exposed to adolescent social defeat. **C)** No changes in either CRF~1~ or CRF~2~ receptor expression was observed in the ventral tegmental area (VTA) or locus coeruleus (LC) in adult male rats exposed to adolescent social defeat. \#P \< 0.05 compared to controls. All data represented as mean values + S.E.M. N = 20 per group.Fig. 3

Enhanced CRF~2~ receptor-serotonin interactions at the level of the dRN may not only increase drug-seeking behaviors, but also the negative affect commonly associated with drug withdrawal and relapse ([@bib87]). Selective antagonism of CRF~2~, but not CRF~1~ receptors globally in the dRN, prevents anxiety-like behaviors of adult rats exposed to adolescent social isolation/disruption and those undergoing amphetamine withdrawal ([@bib101]; [@bib175]; [@bib19]). Therefore, increased expression of CRF~2~ receptors in the dRN following peri-adolescent social stress may have important consequences for negative affect-induced reinstatement of drug seeking in individuals exposed to early-life adversity.

In contrast to social isolation/disruption and defeat, maternal separation decreases CRF~2~ receptor expression while CRF~1~ receptor mRNA is increased in the adult dRN ([@bib23]). This difference in CRF receptor mRNA expression may be a function of the earlier developmental time period in which maternal separation is applied, corresponding to the greatest change in CRF receptor expression over development ([Fig. 1](#fig1){ref-type="fig"}). If these alterations to CRF receptor mRNA are translated to receptor expression and function, this would result in reduced accumbal serotonin and dopamine responses to stress and drugs of abuse ([Fig. 2](#fig2){ref-type="fig"}). On the other hand, dRN serotonergic neurons in adult rats are more responsive to stress ([@bib134]) and prolonged maternal separation increases the number of serotonin neurons and the capacity for serotonin synthesis (as reflected by TPH mRNA) in the ventrolateral subregion of the rat dRN in adulthood ([@bib55]; [@bib171]). This is important because it is the ventrolateral subregion of the dRN that innervates the NAc ([@bib169]), allowing the potential for greater serotonergic responses in the NAc following maternal separation. Maternal separation has been shown to alter serotonin signaling in the NAc, but results can be conflicting. Male rats exhibit either decreased ([@bib124]) or increased ([@bib190]) basal NAc serotonin tissue content in adulthood, while acute stress-induced increases in the serotonergic metabolite 5-HIAA within the NAc of middle-aged (15 month) female rats is exacerbated by maternal separation ([@bib5]). In line with reduced CRF~2~ receptor expression (and presumably attenuated facilitation of dopamine in the NAc), adult rats that experienced maternal separation exhibit blunted NAc dopamine release in response to food rewards either before or following chronic mild stress ([@bib114]; [@bib140]). More aligned with enhanced sensitivity of dRN neurons and greater serotonergic innervation of the NAc, maternal separation augments the accumbal dopaminergic response to both acute amphetamine ([@bib64]) and acute stress ([@bib22]) in adulthood. These contrasting findings may be reconciled by a reward deficiency syndrome which is hypothesized to underlie greater drug seeking following maternal separation ([@bib42]). This syndrome may reflect both dampened tonic and heightened phasic serotonin release in the NAc, respectively resulting in deficient accumbal dopamine to cause a blunted hedonic state that encourages initial drug taking ([@bib176]), but augmented stress-induced dopamine release that would promote drug seeking during abstinence.

Epigenetic processes have emerged as a critical mediator between genes and postnatal environment in conferring risk for later emergence of neuropsychiatric disorders, including addiction (see [@bib30]; [@bib1] for recent reviews). In brief, these processes broadly encompass changes to gene expression that are not secondary to alterations in DNA sequences ([@bib76]). Among the most well studied epigenetic processes are chromatin histone acetylation, which typically promotes gene expression and methylation either of histones or of DNA cytosine-guanine dinucleotide (CpG) sites to result in repression of gene transcription ([@bib156]; [@bib61]). Of relevance, maternal separation in rats has been shown to cause both increased acetylation and hypomethylation of the *Crf* promoter in the adult hippocampus and hypothalamus, leading to increased expression of CRF mRNA and protein ([@bib34]; [@bib177]). Maternal separation has also been shown to increase CRF mRNA specifically in the dRN ([@bib23]). Therefore, neonatal stress-induced epigenetic modifications resulting in increased CRF in the dRN may explain downregulation of the CRF~2~ receptor in rats exposed to maternal separation ([@bib23]), given that ligand and receptor availability are often inversely related (as discussed by [@bib184]). Moreover, CRF-related epigenetic modifications induced by maternal separation are found in first and second generation male and female offspring ([@bib53]). While more studies in this area are necessary, these findings highlight the possibility that the negative consequences of early-life adversity may be transmitted to subsequent generations via epigenetic modifications of neural CRF systems.

To date, epigenetic effects of peri-adolescent stress on either CRF or CRF receptors do not appear to have received much attention, with most studies examining the influence of stress exposure earlier in postnatal life. Hypomethylation at multiple CpG sites of the *Crf2* promoter, which results in greater promoter activity indicating disinhibition of gene expression, has been observed in otherwise healthy individuals who report higher generalized anxiety ([@bib143]). This phenotype is reminiscent of increased anxiety and increased CRF~2~ receptor expression in the dRN of adult rats exposed to social isolation/disruption during adolescence ([@bib100]; [@bib101]; [@bib19]). As such, it is tempting to speculate that long-term upregulation of CRF~2~ receptor expression in the dRN as observed following early-life adversity ([@bib100], [Fig. 3](#fig3){ref-type="fig"}) may result from reduced methylation of the *Crf2* gene, but this is yet to be determined. If true, it may have implications for understanding sex differences in behavioral responses to abused substances following early-life (particularly adolescent) adversity, given that adolescent female rats show a 10-fold higher expression of CRF~2~ mRNA in the dRN compared to males ([@bib104]). This sex specific ontogeny could conceivably increase susceptibility of females to stress-induced changes in epigenetic regulation of the CRF~2~ receptor, with detrimental consequences for serotonergic and dopaminergic signaling in reward pathways.

7. Conclusions {#sec7}
==============

Both human and preclinical studies clearly demonstrate that early-life adversity is associated with a greater propensity for substance abuse in later life. Converging evidence suggests that this may be in part due to alterations of CRF~2~ receptors in the dRN following early-life adversity, which have the ability to promote long-lasting alterations to accumbal monoaminergic transmission and related behaviors. While heightened drug- and alcohol-related behaviors appear similar between pre-adolescent stress (e.g. maternal separation) and stressors later in peri-adolescent development (e.g. social isolation/disruption and social defeat), underlying mechanisms may differ with opposite effects on CFR~2~ receptor expression and activity within the mesolimbic system. Regardless, the CRF~2~ receptor may represent a pharmacotherapeutic target for reducing the negative consequences of early-life adversity, but translational studies are hampered by the lack of CRF~2~ receptor antagonists that effectively cross the blood-brain barrier ([@bib50]; [@bib174]). Recent progress in nanomaterials have been employed to facilitate CRF~2~ receptor ligands crossing the blood-brain barrier to have efficacy at the level of the dRN ([@bib174]), increasing the promise of the CRF~2~ receptor as a novel target for reducing the impact of early-life adversity. However, advancements in preventing and treating substance dependence associated with early-life adversity will continue to be hampered by a paucity of neurobiological studies within preclinical female models. Future work should be directed at understanding sex differences in CRF-serotonin interactions within the dRN and how sexually dimorphic expression of CRF receptors in the dRN, and in dRN serotonin development, translate to greater vulnerability of women to be negatively affected by early-life adversity.
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